◆ Protek = The Korea Exchange (KRX) announced that a cause for a substantial review of listing eligibility has arisen due to violations of accounting standards, following the Securities and Futures Commission's criminal referral.
◆ VDI = The KRX stated that a cause for a substantial review of listing eligibility has arisen as the company disclosed in its audit report submission that its internal accounting control system was deemed inappropriate, after being designated as a stock requiring investor caution last year for the same reason.
◆ TLI = The KRX announced that when the changed largest shareholder is a nominal company or a partnership without legal permits or registration obligations, the largest shareholder must hold the owned shares for one year as a mandatory retention period, and that the company's largest shareholder has completed this mandatory retention.
◆ GW Biotech = It was announced that the company purchased 2 billion KRW worth of the 2nd series anonymous, interest-bearing, unsecured private convertible bonds issued by SNP Genetics, which operates in genome analysis.
◆ Jungwon NCIS = WIMS Co., Ltd. has fully withdrawn its injunction application to prohibit the exercise of voting rights filed with the Seoul Central District Court, as disclosed.
◆ GTG Wellness = Following the submission of an objection letter due to the auditor's disclaimer of opinion, the KRX announced that it will grant an improvement period until April 10 of next year. Trading will be suspended during the improvement period.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
